Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: Evidence for improved neuronal bioenergetics and autophagy procession

Dong Liu, Michael Pitta, Haiyang Jiang, Jong Hwan Lee, Guofeng Zhang, Xinzhi Chen, Elisa M. Kawamoto, Mark P. Mattson

Research output: Contribution to journalArticle

Abstract

Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.

Original languageEnglish (US)
Pages (from-to)1564-1580
Number of pages17
JournalNeurobiology of Aging
Volume34
Issue number6
DOIs
StatePublished - Jun 2013
Externally publishedYes

Fingerprint

Niacinamide
Autophagy
Energy Metabolism
Pathology
Alzheimer Disease
Brain
Lysosomes
Cerebral Cortex
NAD
Hippocampus
Oxidative Stress
Phosphatidylinositol 3-Kinase
Neurons
Proto-Oncogene Proteins c-akt
Neuronal Plasticity
Extracellular Signal-Regulated MAP Kinases
Response Elements
Cognitive Dysfunction
Amyloid
Cyclic AMP

Keywords

  • 3xTgAD
  • Autophagy
  • CREB
  • DLP1
  • Learning and memory
  • Lysosome
  • Mitochondria
  • NAD
  • Nicotinamide
  • P-Akt

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice : Evidence for improved neuronal bioenergetics and autophagy procession. / Liu, Dong; Pitta, Michael; Jiang, Haiyang; Lee, Jong Hwan; Zhang, Guofeng; Chen, Xinzhi; Kawamoto, Elisa M.; Mattson, Mark P.

In: Neurobiology of Aging, Vol. 34, No. 6, 06.2013, p. 1564-1580.

Research output: Contribution to journalArticle

Liu, Dong ; Pitta, Michael ; Jiang, Haiyang ; Lee, Jong Hwan ; Zhang, Guofeng ; Chen, Xinzhi ; Kawamoto, Elisa M. ; Mattson, Mark P. / Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice : Evidence for improved neuronal bioenergetics and autophagy procession. In: Neurobiology of Aging. 2013 ; Vol. 34, No. 6. pp. 1564-1580.
@article{35008c425f04405d911c02fd1bb047e1,
title = "Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: Evidence for improved neuronal bioenergetics and autophagy procession",
abstract = "Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.",
keywords = "3xTgAD, Autophagy, CREB, DLP1, Learning and memory, Lysosome, Mitochondria, NAD, Nicotinamide, P-Akt",
author = "Dong Liu and Michael Pitta and Haiyang Jiang and Lee, {Jong Hwan} and Guofeng Zhang and Xinzhi Chen and Kawamoto, {Elisa M.} and Mattson, {Mark P.}",
year = "2013",
month = "6",
doi = "10.1016/j.neurobiolaging.2012.11.020",
language = "English (US)",
volume = "34",
pages = "1564--1580",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice

T2 - Evidence for improved neuronal bioenergetics and autophagy procession

AU - Liu, Dong

AU - Pitta, Michael

AU - Jiang, Haiyang

AU - Lee, Jong Hwan

AU - Zhang, Guofeng

AU - Chen, Xinzhi

AU - Kawamoto, Elisa M.

AU - Mattson, Mark P.

PY - 2013/6

Y1 - 2013/6

N2 - Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.

AB - Impaired brain energy metabolism and oxidative stress are implicated in cognitive decline and the pathologic accumulations of amyloid β-peptide (Aβ) and hyperphosphorylated tau in Alzheimer's disease (AD). To determine whether improving brain energy metabolism will forestall disease progress in AD, the impact of the β-nicotinamide adenine dinucleotide precursor nicotinamide on brain cell mitochondrial function and macroautophagy, bioenergetics-related signaling, and cognitive performance were studied in cultured neurons and in a mouse model of AD. Oxidative stress resulted in decreased mitochondrial mass, mitochondrial degeneration, and autophagosome accumulation in neurons. Nicotinamide preserved mitochondrial integrity and autophagy function, and reduced neuronal vulnerability to oxidative/metabolic insults and Aβ toxicity. β-Nicotinamide adenine dinucleotide biosynthesis, autophagy, and phosphatidylinositol-3-kinase signaling were required for the neuroprotective action of nicotinamide. Treatment of 3xTgAD mice with nicotinamide for 8 months resulted in improved cognitive performance, and reduced Aβ and hyperphosphorylated tau pathologies in hippocampus and cerebral cortex. Nicotinamide treatment preserved mitochondrial integrity, and improved autophagy-lysosome procession by enhancing lysosome/autolysosome acidification to reduce autophagosome accumulation. Treatment of 3xTgAD mice with nicotinamide resulted in elevated levels of activated neuroplasticity-related kinases (protein kinase B [Akt] and extracellular signal-regulated kinases) and the transcription factor cyclic adenosine monophosphate (AMP) response element-binding protein in the hippocampus and cerebral cortex. Thus, nicotinamide suppresses AD pathology and cognitive decline in a mouse model of AD by a mechanism involving improved brain bioenergetics with preserved functionality of mitochondria and the autophagy system.

KW - 3xTgAD

KW - Autophagy

KW - CREB

KW - DLP1

KW - Learning and memory

KW - Lysosome

KW - Mitochondria

KW - NAD

KW - Nicotinamide

KW - P-Akt

UR - http://www.scopus.com/inward/record.url?scp=84875257081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875257081&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2012.11.020

DO - 10.1016/j.neurobiolaging.2012.11.020

M3 - Article

C2 - 23273573

AN - SCOPUS:84875257081

VL - 34

SP - 1564

EP - 1580

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 6

ER -